You are here

  • Home
  • Archive
  • Volume 85, Issue 6
  • Plasma phosphorylated TDP-43 levels are elevated in patients with frontotemporal dementia carrying a C9orf72 repeat expansion or a GRN mutation

Article info

Article menu
Download PDFPDF
Neurodegeneration
Research paper
Plasma phosphorylated TDP-43 levels are elevated in patients with frontotemporal dementia carrying a C9orf72 repeat expansion or a GRN mutation

Authors

  • Marc Suárez-Calvet Neurology Department, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain Center for Networker Biomedical Research in Neurodegenerative Diseases (CIBERNED), Madrid, Spain PubMed articlesGoogle scholar articles
  • Oriol Dols-Icardo Neurology Department, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain Center for Networker Biomedical Research in Neurodegenerative Diseases (CIBERNED), Madrid, Spain PubMed articlesGoogle scholar articles
  • Albert Lladó Department of Neurology, Alzheimer's Disease and other Cognitive Disorders Unit, Hospital Clínic, Barcelona, Spain PubMed articlesGoogle scholar articles
  • Raquel Sánchez-Valle Department of Neurology, Alzheimer's Disease and other Cognitive Disorders Unit, Hospital Clínic, Barcelona, Spain PubMed articlesGoogle scholar articles
  • Isabel Hernández Memory Clinic of Fundació ACE, Institut Català de Neurociències Aplicades, Barcelona, Spain PubMed articlesGoogle scholar articles
  • Guillermo Amer Neurology Department, Hospital Universitari Son Espases, Majorca, Spain PubMed articlesGoogle scholar articles
  • Sofía Antón-Aguirre Neurology Department, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain Center for Networker Biomedical Research in Neurodegenerative Diseases (CIBERNED), Madrid, Spain PubMed articlesGoogle scholar articles
  • Daniel Alcolea Neurology Department, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain Center for Networker Biomedical Research in Neurodegenerative Diseases (CIBERNED), Madrid, Spain PubMed articlesGoogle scholar articles
  • Juan Fortea Neurology Department, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain Center for Networker Biomedical Research in Neurodegenerative Diseases (CIBERNED), Madrid, Spain PubMed articlesGoogle scholar articles
  • Isidre Ferrer Center for Networker Biomedical Research in Neurodegenerative Diseases (CIBERNED), Madrid, Spain Institut de Neuropatología, Servei Anatomia Patológica, IDIBELL, Hospital Universitari de Bellvitge, University of Barcelona, Barcelona, Spain PubMed articlesGoogle scholar articles
  • Julie van der Zee Department of Molecular Genetics, Neurodegenerative Brain Disease Group, VIB, Antwerp, Belgium Laboratory of Neurogenetics, Institute Born-Bunge, University of Antwerp, Antwerp, Belgium PubMed articlesGoogle scholar articles
  • Lubina Dillen Department of Molecular Genetics, Neurodegenerative Brain Disease Group, VIB, Antwerp, Belgium Laboratory of Neurogenetics, Institute Born-Bunge, University of Antwerp, Antwerp, Belgium PubMed articlesGoogle scholar articles
  • Christine Van Broeckhoven Department of Molecular Genetics, Neurodegenerative Brain Disease Group, VIB, Antwerp, Belgium Laboratory of Neurogenetics, Institute Born-Bunge, University of Antwerp, Antwerp, Belgium PubMed articlesGoogle scholar articles
  • José Luís Molinuevo Department of Neurology, Alzheimer's Disease and other Cognitive Disorders Unit, Hospital Clínic, Barcelona, Spain PubMed articlesGoogle scholar articles
  • Rafael Blesa Neurology Department, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain Center for Networker Biomedical Research in Neurodegenerative Diseases (CIBERNED), Madrid, Spain PubMed articlesGoogle scholar articles
  • Jordi Clarimón Neurology Department, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain Center for Networker Biomedical Research in Neurodegenerative Diseases (CIBERNED), Madrid, Spain PubMed articlesGoogle scholar articles
  • Alberto Lleó Neurology Department, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain Center for Networker Biomedical Research in Neurodegenerative Diseases (CIBERNED), Madrid, Spain PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Alberto Lleó, Neurology Department, Hospital de la Santa Creu i Sant Pau, Sant Antoni M Claret 167, Barcelona 08025, Spain; alleo{at}santpau.es
View Full Text

Citation

Suárez-Calvet M, Dols-Icardo O, Lladó A, et al
Plasma phosphorylated TDP-43 levels are elevated in patients with frontotemporal dementia carrying a C9orf72 repeat expansion or a GRN mutation
Journal of Neurology, Neurosurgery & Psychiatry 2014;85:684-691.

Publication history

  • Received May 28, 2013
  • Revised September 27, 2013
  • Accepted October 29, 2013
  • First published December 4, 2013.
Online issue publication 
April 13, 2016

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions